Clinical trial

Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced…

NCT00463840 · NYU Langone Health, Other · Terminated

Key facts

NCT number NCT00463840
Title Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer
Official title A Phase I/II Study of Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer
Lead sponsor NYU Langone Health, Other
Collaborators Sanofi Industry
Status Terminated
Phase Phase 1/Phase 2
Study type Interventional
Conditions Pancreatic Cancer
Intervention type Drug, Procedure, Radiation
Interventions Oxaliplatin, 5FU, Radiation, Surgery, FOLFOX 6
Enrollment 24
Start date Jun 1, 2004
Primary completion Jul 1, 2010
Completion Oct 1, 2015
First posted Apr 20, 2007
Last update posted Dec 5, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies